Lee L. Swanström (USA-France)

Jie He (China)

Michio Hongo (Japan)


OESO Website

  < back to the Program at a glance

Session 33-34 Clinical Session 7-8


Monday, September 4
10:20 – 12:30 am

Room 15



Controversy on classification/treatments of upper and lower esophageal cancers – Debate


Chairs: Olivier Huber (Switzerland) – William Allum (UK)

Panel: Giovanni de Manzoni (Italy) – Dietmar Lorenz (Germany)



Sessions 33 – Cervical cancers

  • Surgical aspects of proximal esophageal cancer. Katja Ott (Germany)
  • Exclusive radio-chemotherapy. Thomas Zilli (Switzerland)





Sessions 34 – Cancers at the EG junction

Chairs: Hans-Joachim Meyer (Germany) – Giovanni de Manzoni (Italy)

Discussants:  Bruno Zilberstein (Brazil) – William Allum (UK)

  • Rising incidence of adenocarcinoma of the EG junction: what is new in 2017?
    Elfriede Bollschweiler (Germany)
  • Preoperative staging and classifi cation. William Allum (UK)
  • Lymph node involvement according to esophageal invasion. Giovanni de Manzoni (Italy)
  • Siewert II – esophagectomy or gastrectomy. Yves Borbely (Switzerland)
  • Future clinical trial comparing esophagectomy with gastrectomy. Thomas Schmidt (Germany)
  • Ivor-Lewis vs McKeown procedures for EGJ cancers. S.M. Chandramohan (India)
  • Minimal invasive vs open procedure. Lee L. Swanström (USA-France)
  • Extent of lymphadenectomy. Klaus Emmanuel (Austria)
  • Which neoadjuvant treatment?

– Pro chemotherapy. Salah AL-Batran (Germany)

– Pro radio-chemotherapy. Fredrik Klevebro (Sweden)

  • Oligo-metastatic cancer – Impact of surgery. Stefan P. Mönig (Switzerland)








©2016 OESO – SYMPORG SA            webdesign